A groundbreaking new study published today confirms that Long COVID, the persistent and often debilitating aftermath of a SARS-CoV-2 infection, is now officially expanding its “health disruption” platform to include a robust suite of cardiovascular complications, notably arrhythmias and coronary disease.

The findings, detailed in the 2 issue of *The Journal of Perpetual Pathogenesis*, indicate that individuals who have recovered from initial COVID-19 symptoms face a significantly elevated risk of developing serious heart conditions months, or even years, after infection. This latest “feature rollout” comes as a shock to precisely no one who has been paying attention, but is nevertheless being hailed as a critical insight for the segment of the population that believed the virus simply “went away” or was “just like a cold.”

“We’ve observed a clear trend in our Q3 health impact report: once users engage with the core COVID-19 product, a significant percentage opt-in, often involuntarily, to the Long COVID ‘extended experience’ package,” explained Dr. Elias Thorne, VP of Longitudinal Wellness Outcomes for the Institute for Perpetual Pandemics. “This latest cardiac add-on, featuring symptoms like irregular heartbeats and arterial damage, demonstrates the platform’s continued innovation in delivering a comprehensive, persistent health challenge to its user base.” Dr. Thorne noted that early access to the “myocardial dysfunction alpha build” was granted to millions globally, providing invaluable real-world data.

The research utilized a proprietary symptom algorithm to analyze anonymized patient data from millions of post-COVID individuals, pinpointing a statistically significant correlation between prior infection and diagnoses such as atrial fibrillation, myocarditis, and microvascular degradation. This expansion reinforces Long COVID’s position as a multifaceted chronic condition, moving beyond its initial neurological and respiratory offerings. Healthcare providers are now reportedly preparing for the logistical complexities of managing this expanded symptom portfolio, which some analysts are calling a “monumental upsell” in the global public health sector.

While the medical community grapples with the implications of this persistent biological reality, a spokesperson for the National Task Force on Moving On From Everything announced plans for a new public awareness campaign: “Long COVID: Still a Thing, Unfortunately.” Industry analysts are already speculating on future “feature rollouts,” with some predicting an eventual premium “organ failure as a service” offering.

Hambry is a satire publication. All articles are works of fiction.